Market Research Logo

Orion Corp (ORNBV) - Financial and Strategic SWOT Analysis Review

Orion Corp (ORNBV) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Orion Corp (Orion) is a developer of pharmaceuticals and diagnostic tests. The company develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients (APIs) and diagnostic tests. It focuses on developing pharmaceutical products for central nervous system disorders, cancer and respiratory. Orion’s client base consists of healthcare service providers and professionals, such as doctors, pharmacies, veterinarians, hospitals, healthcare centers, clinics and laboratories. The company sells its products in European markets through own human pharmaceuticals sales organization; and in international markets through several collaboration partners. It operates all manufacturing plants and most of its R&D facilities in Finland. Orion is headquartered in Espoo, Finland.

Orion Corp Key Recent Developments

Jul 18,2018: Orion: Half-year financial report January-June 2018
Jun 14,2018: Fermion's new plant operational in Hanko-nearly 100% of production is exported
Jun 13,2018: Achema to cooperate with North China Power Engineering
Mar 20,2018: Orion Board of Arrangement
Feb 28,2018: Orion's Statutory Co-operation Negotiations Completed

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Orion Corp - Key Facts
Orion Corp - Key Employees
Orion Corp - Key Employee Biographies
Orion Corp - Major Products and Services
Orion Corp - History
Orion Corp - Company Statement
Orion Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Orion Corp - Business Description
Business Segment: Diagnostics
Overview
Performance
Business Segment: Pharmaceuticals
Overview
Performance
Key Stats
Business Segment: Pharmaceuticals Sub-division: Animal Health
Overview
Performance
Business Segment: Pharmaceuticals Sub-division: Contract Manufacturing
Overview
Performance
Business Segment: Pharmaceuticals Sub-division: Fermion
Overview
Performance
Business Segment: Pharmaceuticals Sub-division: Proprietary Products
Overview
Performance
Business Segment: Pharmaceuticals Sub-division: Specialty Products
Overview
Performance
Geographical Segment: Finland
Performance
Geographical Segment: North America
Performance
Geographical Segment: Other Countries
Performance
Geographical Segment: Other Europe
Performance
Geographical Segment: Scandinavia
Performance
R&D Overview
Orion Corp - Corporate Strategy
Orion Corp - SWOT Analysis
SWOT Analysis - Overview
Orion Corp - Strengths
Orion Corp - Weaknesses
Orion Corp - Opportunities
Orion Corp - Threats
Orion Corp - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Orion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Orion Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 18, 2018: Orion: Half-year financial report January-June 2018
Jun 14, 2018: Fermion's new plant operational in Hanko-nearly 100% of production is exported
Mar 20, 2018: Orion Board of Arrangement
Feb 28, 2018: Orion's Statutory Co-operation Negotiations Completed
Feb 07, 2018: Orion Group Financial Statement Release for 2017
Jan 04, 2018: Orion to renew operating model of its laboratories
Nov 07, 2017: Professor Heikki Joensuu has been Appointed Vice President of Therapy area Oncology, R&D in Orion
Jul 19, 2017: Orion Group Half-Year Financial Report January-June 2017
Apr 26, 2017: Orion Group Interim Report January–March 2017
Apr 11, 2017: Pharmaceutical leader Orion selects Determine to optimize their global Source-to-Contract effectiveness
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Orion Corp, Key Facts
Orion Corp, Key Employees
Orion Corp, Key Employee Biographies
Orion Corp, Major Products and Services
Orion Corp, History
Orion Corp, Subsidiaries
Orion Corp, Key Competitors
Orion Corp, Ratios based on current share price
Orion Corp, Annual Ratios
Orion Corp, Annual Ratios (Cont...1)
Orion Corp, Annual Ratios (Cont...2)
Orion Corp, Interim Ratios
Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Orion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Orion Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Orion Corp, Performance Chart (2013 - 2017)
Orion Corp, Ratio Charts
Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Orion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report